Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Correction to: Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study,by Cullen KR,Amatya P,Roback MG,Albott CS,Westlund Schreiner M,Ren Y,Eberly LE,Carstedt P,Samikoglu A,Gunlicks-Stoessel M,Reigstad K,Horek N,Tye S,Lim KO,Klimes-Dougan B. J Child Adolesc Psychopharmacol 2018;28(7):437–444. DOI: 10.1089/cap.2018.0030